FDA Announces Public Meeting of Vaccines and Related Biological Products Advisory Committee

Summary

The Food and Drug Administration (FDA) is hosting a public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee to discuss regulatory issues and a recent request to supplement the approved Biologics License Application for COMIRNATY, a COVID-19 vaccine, for a third dose in individuals 16 years of age and older.